ProMIS Neurosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ProMIS Neurosciences, Inc. (PMN) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents13.2912.605.8816.850.81
Short-Term Investments0.030.030.030.040.06
Cash & Short-Term Investments13.3212.635.9116.850.87
Accounts Receivable0.080.080.070.050.03
Inventory0.000.000.000.000.00
Other Current Assets5.510.530.000.120.04
Total Current Assets18.9113.626.9017.580.97
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.08
Long-Term Investments0.000.000.000.000.00
Intangible Assets0.000.000.020.030.03
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.000.020.030.00
Total Assets18.9113.626.9217.621.09
Current Liabilities
Accounts Payable1.747.842.980.920.44
Accrued Liabilities0.481.513.440.521.45
Other Current Liabilities0.480.521.860.000.00
Total Current Liabilities2.229.356.410.921.88
Non-Current Liabilities
Long-Term Debt0.000.000.003.880.00
Other Non-Current Liabilities0.200.521.867.250.00
Total Non-Current Liabilities0.200.521.8610.830.00
Total Liabilities2.429.878.2711.751.88
Stockholders' Equity
Common Stock0.000.000.000.0041.39
Retained Earnings-90.69-93.47-80.25-65.12-55.92
Accumulated Other Comprehensive Income-0.37-0.37-0.20-0.197.17
Additional Paid-in Capital107.5597.5979.107.550.00
Shares Outstanding1.310.760.340.290.00
Total Stockholders' Equity16.493.75-1.355.86-0.80
Total Liabilities & Equity18.9113.626.9217.620.00